scholarly journals Current Data on Lower Prevalence and Age-Related Aggravation of COVID-19 in Japan

2021 ◽  
Vol 4 (2) ◽  
pp. 153-156
Author(s):  
Hiroshi Bando
Keyword(s):  
Total Population ◽  
Current Data ◽  
Lower Prevalence ◽  
Ministry Of Health ◽  
Excess Death ◽  
Age Related ◽  
Crucial Problem

Pandemic COVID-19 has been crucial problem worldwide, and authors have reported less prevalence and excess death in Japan. The Ministry of Health, Labour and Welfare of Japan presented COVID-report of July 2021 Edition. Among them, the number of people diagnosed with COVID-19 in Japan was 796,835 until July 1, 2021, which is equivalent to 0.6% of the total population. Aggravation rate of COVID-19 increases remarkably with aging. The result shows 1, 4, 10, 25, 47, 70< in 30s, 40s, 50s, 60, 70s, 80s< years old, respectively. In contrast, it shows 0.5, 0.2, 0.3 in <9, 10-19, 20-29 years, respectively.

ANTICOAGULANT THERAPY IN CANCER PATIENTS WITH ATRIAL FIBRILLATION. CONSIDERING AGE FACTOR

2020 ◽  
pp. 99-106
Author(s):  
В. И. Потиевская ◽  
А. А. Ахобеков ◽  
М. Ф. Баллюзек
Keyword(s):  
Atrial Fibrillation ◽  
Cancer Patients ◽  
Anticoagulant Therapy ◽  
Oral Anticoagulants ◽  
Direct Oral Anticoagulants ◽  
Current Data ◽  
Related Factors ◽  
Age Related ◽  
Liver And Kidney ◽  
After Cancer

Рассматривается современное состояние вопроса выбора антикоагулянтной терапии при фибрилляции предсердий (ФП) у онкологических больных. Отмечается, что сложность выбора антикоагулянта при злокачественных новообразованиях (ЗНО) определяется такими факторами, как коморбидные сердечно-сосудистые заболевания, нарушения функции печени и почек, метаболические дисфункции, свойственные, прежде всего, пациентам старшей возрастной группы. Приводятся актуальные данные по оценке риска геморрагических и тромбоэмболических осложнений ФП при ЗНО в аспекте возраста. Обсуждаются возможные причины увеличения риска развития ФП во время и после лечения ЗНО, в том числе и в связи с возраст-ассоциированностью этих патологий. Рассмотрены вопросы выбора антикоагулянтов у пациентов, находящихся на активной противоопухолевой терапии, особенно на препаратах из группы прямых оральных антикоагулянтов (ПОАК). Согласно данным обсервационных исследований, именно ПОАК являются перспективным, относительно безопасным и эффективным выбором для онкологических пациентов с ФП, в связи с чем их применение должно активно изучаться в рандомизированных клинических исследованиях с учетом фактора возраста. Подчеркивается, что подбор схемы антикоагулянтной терапии у пациентов с ФП и ЗНО требует междисциплинарного участия кардиологов и онкологов, а часто и гериатров, чтобы индивидуализировать лечение и предложить наиболее эффективную терапию. The current issue of the choice of anticoagulant therapy of atrial fibrillation (AF) in cancer patients is considered. It is noted that the difficulty of choosing an anticoagulant in malignancies is largely determined by age-related factors, such as comorbid cardiovascular diseases, liver and kidney dysfunction, metabolic disorders common for in elderly patients. Current data on the risk assessment of hemorrhagic and thromboembolic complications of AF in cancer patients in the aspect of age presented. During and after cancer treatment, the risk of developing AF can increase, also in connection with the age-associated pathology. Possible reasons of it are discussed. The choice of different anticoagulants groups in patients treated with anticancer therapy, including direct oral anticoagulants (DOAC) is considered. According to available data from observational studies, it is the DOAC that is a promising, relatively safe and effective choice for cancer patients with AF, and therefore their use should be actively studied in randomized trials, considering the factor of age. It is particularly noted that solving this problem requires the interdisciplinary involvement of cardiologists, oncologists, and sometimes, geriatrics, to individualize treatment for each case and to offer the most effective therapy.

scholarly journals INNOVATIVE POLICIES AND TECHNOLOGIES TO INCREASE ACCESS TO HEARING AIDS FOR ADULTS

2019 ◽  
Vol 3 (Supplement_1) ◽  
pp. S828-S829
Author(s):  
Michael Yong ◽  
Amber Willink ◽  
Catherine McMahon ◽  
Bradley McPherson ◽  
Carrie L Nieman ◽  
...  
Keyword(s):  
Hearing Loss ◽  
Hearing Aids ◽  
Total Population ◽  
Hearing Aid ◽  
Insurance Coverage ◽  
Current State ◽  
Hearing Aid Use ◽  
Age Related ◽  
The World ◽  
Age Related Hearing Loss

Abstract As the proportion of older adults in the world’s total population continues to grow, the deleterious downstream health economic outcomes of age-related hearing loss are steadily becoming more prevalent. While recent research has shown that age-related hearing loss is the single greatest modifiable risk factor for dementia, the rate of hearing aid use remains low in many countries across the globe. Reasons for poor uptake are multifactorial and likely involve a combination of factors, ranging from increasing costs of hearing aid technology to lack of widespread insurance coverage. This paper aims to first identify the current state of hearing aid access across the world using eight representative countries as examples. We then provide recommendations on how to facilitate greater access to hearing aids for consumers by addressing areas in regulation, technology, reimbursement, and workforce.

scholarly journals Australia (Melbourne)

1992 ◽  
Vol 16 (9) ◽  
pp. 552-554
Author(s):  
David Ames
Keyword(s):  
Third World ◽  
Total Population ◽  
Standard Of Living ◽  
Health Costs ◽  
Cultural Groups ◽  
Aboriginal Community ◽  
Age Related ◽  
English Speaking ◽  
Post War ◽  
First World

Australia is a unique, geologically ancient island continent. Its flora and fauna are unlike those found anywhere else and the same may be said of its people, politics and health services. The population of 17.3 millions represents a multicultural mix, with an anglo-celtic core conflated by sustained post-war immigration from southern Europe, Turkey, southeast Asia and south America. One in five current Australians was born elsewhere, one in ten comes from a non-English speaking background, and a quarter of those born here have a parent who was born overseas. Aboriginals and Torres Strait Islanders form 1.4% of the total population. They have third world mortality figures but die of first world diseases, their life expectancy being 20 years less than that of other Australians. Two hundred and four years after what they see as the British invasion, their standard of living lags far behind all other socio-cultural groups in the country. Most members of the Aboriginal community do not live long enough to develop Alzheimer's disease, but it and other age-related diseases are emerging as the major determinants of health costs as Australia moves towards the 21st century.

The prevalence of early childhood autism: comparison of administrative and epidemiological studies

1976 ◽  
Vol 6 (1) ◽  
pp. 89-100 ◽  
Author(s):  
Lorna Wing ◽  
Sybil R. Yeates ◽  
Lorna M. Brierley ◽  
Judith Gould
Keyword(s):  
Early Childhood ◽  
Total Population ◽  
Local Authority ◽  
Epidemiological Studies ◽  
Case Note ◽  
Lower Prevalence ◽  
Prevalence Rates ◽  
Handicapped Children ◽  
Prevalence Studies ◽  
Wide Range

SynopsisThe results of surveys and inquiries to identify autistic children, carried out in England and Wales, the U.S.A. and Denmark, are compared. Three studies, in each of which either a total population of children or a wide range of handicapped children was screened, using case-note inspection and interviews, all estimated the prevalence of the autistic syndrome to be between four and five children per 10,000 aged under 15 years. Inquiries that counted diagnosed cases only or that relied upon local authority records produced much lower prevalence rates for the autistic syndrome. The reasons for this are examined, and the implications for prevalence studies of handicapping conditions are discussed.

scholarly journals EXCESS MORTALITY FROM COVID-19. WEEKLY EXCESS DEATH RATES BY AGE AND SEX FOR SWEDEN.

2020 ◽  
Author(s):  
Karin Modig ◽  
Marcus Ebeling
Keyword(s):  
Life Expectancy ◽  
Excess Mortality ◽  
Total Population ◽  
Total Mortality ◽  
Death Rates ◽  
Excess Death ◽  
Relative Risks ◽  
All Cause Mortality ◽  
The Difference ◽  
Age And Sex

Objectives: Mortality from Covid-19 is monitored in detail both within as well as between countries with different strategies against the virus. However, death counts and relative risks based on crude numbers can be misleading. Instead, age specific death rates should be used for comparability. Given the difficulty of ascertainment of Covid-19 specific deaths, excess all-cause mortality is currently more appropriate for comparisons. By estimating age- and sex-specific death rates we aim to get more accurate estimates of the excess mortality attributed to Covid-19, as well as the difference between men and women in Sweden. Design: We make use of Swedish register data about total weekly deaths, total population at risk, and estimate age- and sex-specific weekly death rates for 2020 and the 5 previous years. The data is provided by Statistics Sweden. Results: From the first week of April and onwards, the death rates at all ages above 60 are higher than those in previous years in Sweden. Persons above age 80 are dis-proportionally more affected, and men suffer higher levels of excess mortality than women at all ages with 75% higher death rates for males and 50% higher for females. Current excess mortality corresponds to a decline in remaining life expectancy of 3 years for men and 2 years for women. Conclusion: The Covid-19 pandemic has so far had a clear and consistent effect on total mortality in Sweden, with male death rates being comparably more affected. What consequences the pandemic will eventually have on mortality and life expectancy will depend on the progression of the pandemic, the extent that some of the deaths would have occurred in the absence of the pandemic, only somewhat later, the consequences for other health conditions, as well as the health care sector at large.

Factor VII Antigen Levels in a Healthy Blood Donor Population

1994 ◽  
Vol 72 (01) ◽  
pp. 021-027 ◽  
Author(s):  
P R Howard ◽  
E G Bovill ◽  
J Pike ◽  
W R Chruch ◽  
R P Tracy
Keyword(s):  
Total Population ◽  
Solid Phase ◽  
Reference Interval ◽  
Factor Vii ◽  
Specific Reference ◽  
Reference Ranges ◽  
Age Related ◽  
Gender And Age ◽  
Donor Population ◽  
The Mean

SummaryWe determined factor VII antigen (FVIIag) levels in 705 healthy blood donors ranging in age from 17 to 79 years using a two-site solid-phase enzyme immunoassay developed in our laboratory. The mean (± SD) FVIIag level for the total population was 102 ± 31%. FVIIag levels for men (n = 375) and women (n = 330) were 101 ± 28% and 103 ± 33%, respectively. A significant increase in FVIIag was observed with age in both men (r = 0.25, p <0.0001) and women (r = 0.35, p <0.0001). FVIIag levels were significantly higher in women > 60 years when compared to men (median women: 125%; median men: 111%; p <0.05). On a subset of the study group (n = 45), FVIIag levels were correlated to total cholesterol (r = 0.27, p = 0.08) and triglyceride (r = 0.41, p <0.01). Assuming the commonly used reference interval of 60-140% for FVII, the frequencies of FVIIag values for <60% and >140% using our assay were 2.1% and 9.2%, respectively. Gender and age-related differences in FVIIag levels must be considered in a reference interval. We further suggest that assay-specific reference ranges be established, which may include values outside the commonly used values of 60-140%.

scholarly journals A systematic review assessing the existence of pneumothorax-only variants of FLCN. Implications for lifelong surveillance of renal tumours

2021 ◽  
Author(s):  
Kenki Matsumoto ◽  
Derek Lim ◽  
Paul D. Pharoah ◽  
Eamonn R. Maher ◽  
Stefan J. Marciniak
Keyword(s):  
Systematic Review ◽  
Skin Lesions ◽  
Confounding Factors ◽  
Lower Prevalence ◽  
Pathogenic Variants ◽  
Age Related ◽  
Pubmed Database ◽  
Renal Tumours ◽  
Pulmonary Cysts ◽  
Genetic Features

AbstractIndividuals with Birt–Hogg–Dubé syndrome (BHDS) may develop fibrofolliculomas, pneumothorax and/or renal cell carcinoma (RCC). Currently, all patients with pathogenic FLCN variants are recommended to have renal surveillance. It has however been suggested that some FLCN variants only cause pneumothorax, which would make surveillance unnecessary in certain cases. This review assesses this possibility. We provide an up-to-date analysis of clinical and genetic features of BHDS. The PUBMED database was systematically searched to find all articles describing patients with pathogenic FLCN variants. The relevant clinical and genetic features of these patients were recorded and analysed. The prevalence of pneumothorax, pulmonary cysts, RCC and characteristic skin lesions in BHDS were 50.9% (n = 1038), 91.9% (n = 720), 22.5% (n = 929) and 47.9% (n = 989), respectively. There was a higher prevalence of pneumothoraces (p < 0.0001) but lower prevalence of dermatological findings (p < 0.0001) in patients from East Asia compared to North America or Europe. Of the 194 pathogenic FLCN variants, 76 could be defined as ‘pneumothorax-only’. Pneumothorax only pathogenic variants (POPVs) were distributed throughout the gene, and there were no statistical differences in variant type. The majority of POPVs (65/76) affected no more than three individuals. Individuals with ‘POPVs’ also tended to be younger (45 vs. 47 years, p < 0.05). Many apparent POPVs in the literature could result from variable expressivity, age-related penetrance and other confounding factors. We therefore recommend that all individuals found to carry a pathogenic FLCN variant be enroled in lifelong surveillance for RCC.

Identification of Transgender People With Cancer in Electronic Health Records: Recommendations Based on CancerLinQ Observations

2021 ◽  
Vol 17 (3) ◽  
pp. e336-e342
Author(s):  
Ash B. Alpert ◽  
George A. Komatsoulis ◽  
Stephen C. Meersman ◽  
Elizabeth Garrett-Mayer ◽  
Suanna S. Bruinooge ◽  
...  
Keyword(s):  
Gender Identity ◽  
Electronic Health Records ◽  
Total Population ◽  
Female Gender ◽  
The United States ◽  
Current Data ◽  
Health Records ◽  
Transgender People ◽  
Transgender Identity ◽  
Electronic Health

PURPOSE: Cancer prevalence and outcomes data, necessary to understand disparities in transgender populations, are significantly hampered because gender identity data are not routinely collected. A database of clinical data on people with cancer, CancerLinQ, is operated by the ASCO and collected from practices across the United States and multiple electronic health records. METHODS: To attempt to identify transgender people with cancer within CancerLinQ, we used three criteria: (1) International Classification of Diseases 9/10 diagnosis (Dx) code suggestive of transgender identity; (2) male gender and Dx of cervical, endometrial, ovarian, fallopian tube, or other related cancer; and (3) female gender and Dx of prostate, testicular, penile, or other related cancer. Charts were abstracted to confirm transgender identity. RESULTS: Five hundred fifty-seven cases matched inclusion criteria and two hundred and forty-two were abstracted. Seventy-six percent of patients with Dx codes suggestive of transgender identity were transgender. Only 2% and 3% of the people identified by criteria 2 and 3 had evidence of transgender identity, respectively. Extrapolating to nonabstracted data, we would expect to identify an additional four individuals in category 2 and an additional three individuals in category 3, or a total of 44. The total population in CancerLinQ is approximately 1,300,000. Thus, our methods could identify 0.003% of the total population as transgender. CONCLUSION: Given the need for data regarding transgender people with cancer and the deficiencies of current data resources, a national concerted effort is needed to prospectively collect gender identity data. These efforts will require systemic efforts to create safe healthcare environments for transgender people.

scholarly journals Age-related changes of cholestanol and lathosterol plasma concentrations: an explorative study

2019 ◽  
Vol 18 (1) ◽  
Author(s):  
Monica Gelzo ◽  
Maria Donata Di Taranto ◽  
Concetta Sica ◽  
Antonio Boscia ◽  
Francesco Papagni ◽  
...  
Keyword(s):  
Correlation Coefficient ◽  
Total Population ◽  
Cholesterol Metabolism ◽  
Plasma Concentrations ◽  
Inherited Disorders ◽  
Explorative Study ◽  
Flame Ionization ◽  
Cholesterol Levels ◽  
Age Related ◽  
Sterol Profile

Abstract Background Cerebrotendinous xanthomatosis (CTX) and Lathosterolosis represent two treatable inherited disorders of cholesterol metabolism that are characterized by the accumulation of cholestanol and lathosterol, respectively. The age of the patients suspected of having these disorders is highly variable due to the very different phenotypes. The early diagnosis of these disorders is important because specific therapeutic treatment could prevent the disease progression. The biochemical diagnosis of these defects is generally performed analyzing the sterol profile. Since age-related levels of these sterols are lacking, this study aims to determine a preliminary comparison of plasma levels of cholestanol and lathosterol among Italian unaffected newborns, children and healthy adults. Methods The sterols were extracted from 130 plasma samples (24 newborns, 33 children and 73 adults) by a liquid-liquid separation method and quantified by gas chromatography coupled with a flame ionization detector. Results Cholesterol, cholestanol and lathosterol levels together with the cholestanol/cholesterol and lathosterol/cholesterol ratios are statistically different among the three groups. Cholesterol levels progressively increased from newborns to children and to adults, whereas cholestanol/cholesterol and cholestanol/lathosterol ratios progressively decreased from newborns to children and to adults. Lathosterol levels were higher in adults than in both newborns and children. In the total population a positive correlation was observed between cholesterol levels and both cholestanol (correlation coefficient = 0.290, p = 0.001) and lathosterol levels (correlation coefficient = 0.353, p <  0.0001). Conclusions Although this study can only be considered an explorative experience due to the low number of analyzed samples, we revealed several differences of plasma cholestanol and lathosterol levels and their ratios to cholesterol levels among newborns, children and adults. These evidences indicate the need of age-related reference values of cholestanol and lathosterol concentrations, including also newborns and children.

scholarly journals Age-related features of the manifestation of non-contagious pathology and metabolic disorders of liver in broiler chickens

2020 ◽  
Vol 17 ◽  
pp. 00139
Author(s):  
Marina P. Semenenko ◽  
Elena V. Kuzminova ◽  
Denis V. Osepchuk ◽  
Vladimir A. Grin ◽  
Ksenia A. Semenenko ◽  
...  
Keyword(s):  
Blood Serum ◽  
Broiler Chickens ◽  
Metabolic Disorders ◽  
Total Population ◽  
Industrial Enterprise ◽  
Liver Pathology ◽  
Hepatic Parenchyma ◽  
Age Related ◽  
Causes Of Mortality

The article presents the data on the study of age-related features of non-contagious pathology in broiler chickens, as well as the level of metabolic processes in liver of healthy poultry and poultry with diseases. The results of the studies indicate that in the conditions of an industrial enterprise specializing in meat poultry rearing, poultry mortality in different age periods ranged from 3 to 5 % of the total population. In the structure of the causes of mortality of broiler chickens from the 8th to the 15th day, an increase in mortality from hepatopathies was registered, and by the 25th day of life hepatosis was recorded in the bulk of the dead poultry. Biochemical monitoring of blood serum in poultry with signs of liver pathology revealed an increase in the level of ALAT, β-globulins, and the “inflammation syndrome” of the hepatic parenchyma was confirmed by a positive thymol test. Long-term consumption of feed contaminated with mycotoxins by broilers led to the deterioration in the health of the poultry, an imbalance in liver and the development of general metabolic disorders of the poultry organism.

Sign in / Sign up

Export Citation Format

Share Document